Harmony Biosciences Holdings Inc initiated its world-wide section 3 registrational demo, the TEMPO research, to examine the basic safety and efficacy of pitolisant as a remedy for excessive daytime sleepiness (EDS) and behavioral indications in sufferers aged 6 yrs and more … [Read more...]